In FGFR1, expression of truncated splice variants such as FGFR1β, which lacks the first Ig-like domain, enhances ligand binding affinity and mitogenic signaling and has been associated with aggressive behavior in breast cancer and other solid tumors [81]. The gene discussed is FGFR1; the disease is breast carcinoma.